CTRI/2013/12/004215招募中2 期
A multicentric single blind, randomized, parallel group, comparative study to compare the efficacy and safety of Coded Unani formulations UNIM 001+UNIM003 with Psoralen in the treatment of Bars (vitiligo )
Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 532 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 532
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients with clinically diagnosed dermatomal and non-dermatomal vitiligo
- •2.Subjects with 8 -50 years of age.
- •3.Either gender
- •4.With any duration of disease, site, extension and distribution of lesions
- •5.Willingness to give written informed consent form.
排除标准
- •1.Subjects with active vitiligo treatment with other drugs/systems
- •2.Non-cooperative subjects
- •3.H/o of drug or alcohol abuse, chronic smokers not willing to abstain from smoking during the study period
- •4.Any clinically significant abnormality identified on physical examination or laboratory tests
- •5.Subjects having any systemic disease and other skin diseases.
- •6.Subjects with known allergies
- •7.Impaired Cardiac, Hepatic and Renal function
- •8.History of malignancy
- •9.Concomitant use of any other antioxidants
- •10.History of hypersensitivity to any of the investigational drugs/herbal medicine.
- •11.Receiving any other investigational product within 4 weeks
- •12.Any medical condition, where physician feels participation in the study could be detrimental to subjects well being.
- •13.Uncontrolled infection
- •14.Pregnant and lactating women.
研究者
相似试验
已完成
4 期
A post licensure clinical trial to evaluate the immunogenicity & safety of BE?s combined liquid pentavalent DTwP-rHepB-HIB vaccine (Combe Five) administered to healthy Indian infants in comparison with a licensed Pentavac SD? vaccine available in Indian marketCTRI/2011/04/001681Biological ELimited408
已完成
3 期
A phase III clinical trial to study the safety and immunogenicity of BEs combined pentavalent DTwP-rHepB-HIB liquid vaccine administered to 6-8 week old healthy Infants of either gender in comparison with a marketed vaccine.CTRI/2009/091/000456Biological E Limited Azamabad Hyderabad AP India90
已完成
4 期
A phase IV clinical trial to study the safety and immunogenicity of a single booster dose of BEs Tetanus Toxoid vaccine BETT administered to 18-50 year old healthy Indian adults of either gender.CTRI/2009/091/000539Biological E Limited90
已完成
2 期
A clinical study to evaluate efficacy of a copper containing intrauterine device (Coated Copper- T) in reducing bleeding side effects.CTRI/2016/01/006535HLL Lifecare Limited176
已完成
3 期
Comparison of Efonidipine 40 mg and Chlorthalidone 12.5 mg combination tablets versus Cilnidipine 10 mg and Chlorthalidone 12.5 mg combination tablets in the management of high blood pressure.CTRI/2020/08/027364Zuventus Healthcare Limited240